Performance of clinical trials is a departmental priority.
The department and affiliated programs are conducting investigational
studies of treatments for genitourinary cancer and other conditions
with the goal of improving diagnosis, treatment, and follow-up
of urologic disease. There are over 30 open studies analyzing
the effects of drug therapies, treatment interventions, nutritional
and lifestyle interventions, and active surveillance.
The clinical trials group, overseen by the G-CEPS program,
manages protocols for both intervention trials and observational
research for the department. Studies are funded by the National
Institutes of Health, industry and intramurally. Study protocols
include research collaborations with cancer cooperative groups,
the National Cancer Institute, other academic medical centers,
and private industry. A comprehensive listing of open studies
can be found on this page, and in the UCSF Helen Diller Family
Comprehensive Cancer Center's web searchable database located
Improvements made in clinical care for urologic disorders at
UCSF are shared with other health professionals and yield improved
health care worldwide.
Our research group recently completed the Molecular
Effects of Nutrition Supplements (MENS) trial.
The MENS trial is a NCI funded randomized clinical trial of
men with prostate cancer, opting for active surveillance. This
trial is designed to better understand how two nutritional supplements,
lycopene (tomato extract) and fish oil, affect the prostate tissue
This trial is closed to enrollment.
Urology Clinical Trials Staff
Hazel Dias, Clinical Research Coordinator
Aleksey Ignatov, Clinical Research Coordinator
Sarah Joost, Clinical Research Coordinator
Imelda Tenggara, Clinical Research Coordinator,
Clinical Trials Office
UCSF Department of Urology
San Francisco, CA 94143-1695
The Genitourinary Cancer Epidemiology and Population
Science (G-CEPS) program encompasses all studies involving patients
or populations conducted by or in collaboration with Urology.